I will leave clause 18 to my hon. Friend the Minister, who may talk about that issue. I am more concerned about the fact that health trusts other than strategic health authorities will have someone specifically responsible for such drugs. That is the most important thing, no matter who in the system does it.
I am concerned about the fact that the hon. Member for South Cambridgeshire (Mr. Lansley) talked about the weakness of the codes that are likely to come into being to protect us from health-care acquired infections. I may be wrong, but I thought that he said that the draft code was not good enough, but that he had not seen it. That seems a bit of a jump that should be addressed. I understand that the Bill will give the Secretary of State the power to provide a statutory code of practice and to place a duty on NHS bodies to comply with that code, as well as the power for the Healthcare Commission to issue improvement notices to non-compliant bodies. I spoke to Healthcare Commission representatives at a meeting yesterday and they want the Bill to ensure that that can happen. They also want the existing intervention powers of the Secretary of State and Monitor—the Independent Regulator of NHS Foundation Trusts—to be used to take enforcement action.
Health Bill
Proceeding contribution from
Kevin Barron
(Labour)
in the House of Commons on Tuesday, 29 November 2005.
It occurred during Debate on bills on Health Bill.
Type
Proceeding contribution
Reference
440 c172-3 
Session
2005-06
Chamber / Committee
House of Commons chamber
Subjects
Librarians' tools
Timestamp
2024-04-21 11:18:50 +0100
URI
http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_281304
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_281304
In Solr
https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_281304